Introduction {#sec1}
============

The dental pulp consists of various cells, matrices, nerves, vessels, and collagen fibers, which are important to maintain the form and function of teeth.[@bib1] Dental pulp cells (DPCs), comprising the major cell lineage of dental pulp tissue, have multipotent differentiation characteristics.[@bib2] Throughout life, they remain active and function to repair impaired dentine by generating odontoblasts.[@bib3]

Apoptosis, also known as programmed cell death, is important to control cell numbers and tissue size, and can protect the organism from rogue cells that threaten homeostasis.[@bib4] This occurs in healthy dental pulp, and apoptotic cells are more numerous in the crown, mostly in a sub-odontoblastic locations, contributing to regulation of the pulp cell population.[@bib5] Apoptosis of DPCs was reported to be induced by the resin monomer Bis-GMA,[@bib6] lipopolysaccharides,[@bib7] or some capping agents during pulp wound healing after cavity preparation.[@bib8]^,^[@bib9] Hydrogen peroxide (H~2~O~2~), a reactive oxygen species (ROS), with a greater lifetime than other intracellular ROS, can easily diffuse across membranes and was proposed to be the predominant ROS involved in cell functions.[@bib10] Further, low concentrations of H~2~O~2~ were found to reduce cell viability and induce apoptosis in human DPCs (hDPCs).[@bib11]

Melatonin (N-acetyl-5-methoxytryptamine) is a neurohormone mainly produced by the pineal gland. It is involved in many important biological processes like circadian regulation, immune modulation, anti-inflammation, neuroprotection, and tumor suppression.[@bib12], [@bib13], [@bib14], [@bib15] It also regulates multiple cellular processes such as the proliferation and differentiation of various cell types.[@bib16], [@bib17], [@bib18] Moreover, accumulating evidence suggests that melatonin also regulates apoptosis in different cell types. For most tumor cells, it enhances apoptosis and could function with some chemotherapeutics to suppress tumor growth.[@bib13] Moreover, melatonin can also induce apoptosis in normal human platelets.[@bib19] In contrast, for most normal cells, apoptosis is reduced by melatonin. For example, melatonin was found to protect bone marrow mesenchymal stem cells and adipose-derived stem cells from H~2~O~2~-induced apoptosis.[@bib20]^,^[@bib21]

Our previous studies show that physiological concentrations of melatonin can inhibit proliferation and promote odontogenic differentiation of hDPCs,[@bib18] but its effect on apoptosis remains unknown. Here, we used H~2~O~2~ to induce apoptosis in hDPCs, aiming to explore the effect of physiological concentrations of melatonin on H~2~O~2~-induced toxicity.

Materials and methods {#sec2}
=====================

Cell culture and identification {#sec2.1}
-------------------------------

After approval by the Ethical Review Committee and obtaining signed informed consent from all subjects, hDPCs were derived freshly from carious-free and intact human third molars extracted from male and female patients aged 18 to 25 (n = 13). Pulp tissues were isolated aseptically from teeth split with a chisel, minced into pieces, enzymatically digested with collagenase type I, and then cultured in the Dulbecco\'s Modified Eagle\'s medium (DMEM) supplemented with antibiotics (100 U/mL penicillin, 100 μg/mL streptomycin) and 20% fetal bovine serum (FBS). Through successive subculture, cells were expanded for further experiments (passage 3--5). All reagents for this were purchased from Gibco (Grand Island, NY, USA).

The origin of hDPCs was identified by immunocytochemical staining for the epithelial cell marker cytokeratin (1:100, BOSTER, Wuhan, China) and the mesenchymal cell marker vimentin (1:100, BOSTER). HEK293T cells (cytokeratin-positive epithelial cells from embryonic kidney) were stained for cytokeratin as a positive control, whereas primary antibodies were replaced with phosphate-buffered saline (PBS, Gibco) as a negative control. Photographs were taken with an inverted microscope (Zeiss, Göttingen, Germany).

Cell viability assay {#sec2.2}
--------------------

Cell viability of hDPCs was estimated by Cell Counting Kit-8 (CCK-8; Dojindo, Kumamoto, Japan). Cells were seeded in 96-well plates (6 × 10^3^ cells/well) and allowed to adhere overnight before exposure to varying concentrations of H~2~O~2~ (0, 250, 500, 1000 μmol/L), melatonin (Sigma--Aldrich, St Louis, MO, USA) (0, 10^−12^,10^−10^,10^−8^ mol/L), and melatonin with H~2~O~2~. After 24 h, cells were gently washed with PBS and media were substituted with 10% CCK-8 in new media; cells were then incubated for 2 h at 37 °C. Absorbance at 450 nm was measured using a spectrophotometer (BioTek, Winooski, VT, USA). This experiment was repeated at least three times.

H~2~O~2~ and melatonin treatments {#sec2.3}
---------------------------------

To investigate the effect of melatonin on H~2~O~2~-induced apoptosis, 500 μmol/L H~2~O~2~ and 10^−8^ mol/L melatonin (based on cell viability results) were used. hDPCs were seeded in 60-mm cell culture dishes (2.3 × 10^5^ cells/dish), allowed to adhere overnight, and incubated with serum-free DMEM for 24 h. Next, media were substituted with low-serum DMEM (containing 0.5% FBS), and cells were treated with 500 μmol/L H~2~O~2~, 10^−8^ mol/L melatonin, or both, for 24 h. Cells treated only with low-serum DMEM served as a control.

Morphological analysis of nuclei {#sec2.4}
--------------------------------

The apoptotic morphology of hDPCs was assessed with the chromatin dye 4′,6-diamidino-2-phenylindole (DAPI). After melatonin and (or) H~2~O~2~ treatments, as indicated, hDPCs were fixed in 4% paraformaldehyde at 4 °C overnight and incubated with DAPI (Roche, Basel, Swiss) for 3 min at room temperature. Stained nuclei were observed under a fluorescence microscopy (Zeiss). Apoptotic bodies, condensed and deformed nuclei, and the total number of DAPI-stained nuclei were counted in nine randomly-selected areas for at least three independent experiments. Greater than 1000 cells from each sample were captured and the ratio of apoptosis was calculated.

Flow cytometric analysis of apoptosis, intracellular ROS levels, and mitochondrial membrane potential {#sec2.5}
-----------------------------------------------------------------------------------------------------

Apoptosis of hDPCs was evaluated using an Annexin V-FITC/propidium iodide (PI) double staining assay (BD, Bergen, NJ, USA). After treatments with melatonin and (or) H~2~O~2~, hDPCs were collected, rinsed, and incubated with Annexin V-FITC and PI for 15 min at room temperature. Cell samples were then analyzed by flow cytometry (Beckman Coulter, Brea, CA, USA). The proportions of Annexin V-positive cells were recorded as apoptotic rates.

Intracellular ROS levels were measured using CellROX® Green (Invitrogen, Grand Island, NY, USA). Upon H~2~O~2~ and melatonin treatment, hDPCs were collected and incubated with CellROX® reagent for 1 h at 37 °C, washed with PBS for three times, and analyzed by flow cytometry. Intracellular ROS levels were indicated by the mean intensity of green fluorescence.

A Mitochondrial Membrane Potential Detection Kit (JC-1; Beyotime, Shanghai, China) was employed to analyze mitochondrial membrane potential (ΔΨm) in hDPCs. After various treatments, hDPCs were collected and incubated with JC-1 staining solution for 20 min at 37 °C. After rinsing, the cells were resuspended for flow cytometry. The ratio of red (J-aggregates)/green (JC-1 monomer) fluorescence was calculated, which represents ΔΨm.

A total of 10,000 cells were harvested from each sample for these flow cytometric analyses. Experiments were repeated at least three times.

Statistical analysis {#sec2.6}
--------------------

Data are presented as mean ± standard deviation (SD). One-way ANOVA was used to compare means between multiple groups and least significant difference (LSD) was used for post-hoc analysis. All *P* values less than 0.05 were considered statistically significant. Statistical analysis was performed using SPSS 20.0 (IBM Corp, Armonk, NY, USA).

Results {#sec3}
=======

Characteristics of cultured hDPCs {#sec3.1}
---------------------------------

Spindle-like hDPCs migrated from the small pieces of dental pulp tissue by day 7 ([Fig. 1](#fig1){ref-type="fig"}A (i)), grew to a near confluent state after 14 days ([Fig. 1](#fig1){ref-type="fig"}A(ii)), and were subcultured and further purified by distinct digestion in vitro. Cells cultured were positive for the mesenchymal marker vimentin ([Fig. 1](#fig1){ref-type="fig"}B(i)) and negative for the epithelial marker cytokeratin ([Fig. 1](#fig1){ref-type="fig"}B(ii)).Figure 1The isolation, culture, and identification of human dental pulp cells (hDPCs). (A) Primary culture: cells migrated from human dental pulp tissue pieces after 7 days of culture (i). hDPCs grew to a near-confluent state after 14 days of incubation (ii). (B) Identification of hDPCs by immunocytochemical staining: hDPCs were positive for vimentin (i) and negative for cytokeratin (ii). The negative control (iii) and positive control for cytokeratin (iv) are shown. Scale bars = 100 μm.Figure 1

Viability of hDPCs {#sec3.2}
------------------

From CCK-8 results, H~2~O~2~ obviously decreased viability of hDPCs in a concentration-dependent manner (*P* \< 0.05; [Fig. 2](#fig2){ref-type="fig"}A). Further, a reduction in cell viability by 16--20% was observed in hDPCs treated with various concentrations of melatonin (10^−12^, 10^−10^, 10^−8^ mol/L) for 24 h (*P* \< 0.01; [Fig. 2](#fig2){ref-type="fig"}B). Compared to that with H~2~O~2~ alone, cell viability was also reduced in groups treated with melatonin (10^−12^, 10^−10^, 10^−8^ mol/L) and H~2~O~2~ (*P* \< 0.05), which was most obvious with 10^−8^ mol/L melatonin and H~2~O~2~ (*P* \< 0.001, vs. H~2~O~2~ alone; *P* \< 0.05, vs. 10^−12^ mol/L melatonin and H~2~O~2~; [Fig. 2](#fig2){ref-type="fig"}C).Figure 2Cell viability of human dental pulp cells (hDPCs), as assessed by CCK-8 assays, exposed to different concentrations of H~2~O~2~ (0--1000 μmol/L) for 24 h (A), melatonin (0--10^−8^ mol/L) for 24 h (B), or melatonin (10^−12^ -- 10^−8^ mol/L) with H~2~O~2~ (500 μmol/L) for 24 h (C). Data are presented as the mean ± SD (*n* = 4, 4, and 3, respectively). *\*P* \< 0.05, ^*\*\**^*P* \< 0.01, ^*\*\*\**^*P* \< 0.001 vs. control; ^*\#*^*P* \< 0.05, ^\#*\#*^*P* \< 0.01, ^\#\#\#^*P* \< 0.001, vs. H~2~O~2~ alone; ^&^*P* \< 0.05, ^&&&^*P* \< 0.001.Figure 2

Morphological changes in nuclei and apoptosis of hDPCs {#sec3.3}
------------------------------------------------------

Based on DAPI staining, nuclei of hDPCs in control and melatonin groups were mostly round and homogeneously-stained, whereas in H~2~O~2~-exposed groups, condensed and deformed nuclei were observed ([Fig. 3](#fig3){ref-type="fig"}A). The ratio of apoptotic cells with condensed and deformed nuclei was significantly increased when hDPCs were co-treated with H~2~O~2~ and melatonin (*P* \< 0.001; [Fig. 3](#fig3){ref-type="fig"}C).Figure 3Effect of melatonin on H~2~O~2~-induced apoptosis in human dental pulp cells (hDPCs). (A) Morphological changes in nuclei of hDPCs were evaluated by DAPI staining. Apoptotic cells are indicated by the arrows; scale bars = 50 μm. (B) Representative dot plots of different groups based on Annexin V/PI staining, as measured by flow cytometry. The fluorescence intensity for Annexin V/FITC is plotted on the x-axis, with PI plotted on the y-axis. The rate of apoptosis is indicated by DAPI staining (C) and by percentages of Annexin V-positive cells (D). Data are presented as the mean ± SD (*n* = 4), ^∗∗^*P* \< 0.01, ^∗∗∗^*P* \< 0.001, vs. control; ^*\#\#*^*P* \< 0.01, ^*\#\#\#*^*P* \< 0.001, vs. H~2~O~2~ alone.Figure 3

By Annexin V-FITC/PI staining, the apoptosis rate in each group was calculated as the percentage of Annexin V-positive cells. As shown in [Fig. 3](#fig3){ref-type="fig"}B, D, 5.50 ± 0.73% of hDPCs in the control group were apoptotic. In the H~2~O~2~ group, this rate increased to 7.85 ± 1.46% (*P* \< 0.01), whereas in the group co-treated with H~2~O~2~ and melatonin, this rate was remarkably increased to 10.67 ± 0.88% (*P* \< 0.01, compared to H~2~O~2~ alone). However, with melatonin alone, the apoptotic rate was 5.48 ± 0.99%, and not significantly different than that in the control group.

Altered ROS levels and mitochondrial membrane potential in hDPCs {#sec3.4}
----------------------------------------------------------------

Based on CellROX® Green staining, intracellular ROS levels were indicated by the mean fluorescence. As in [Fig. 4](#fig4){ref-type="fig"}A, B, these levels were significantly elevated by H~2~O~2~ (*P* \< 0.001), and co-treatment with melatonin resulted in an even higher level of ROS (*P* \< 0.05).Figure 4Effect of melatonin on H~2~O~2~-induced reactive oxygen species (ROS) production and mitochondrial membrane potential loss in human dental pulp cells (hDPCs). (A) Representative histogram of CellROX® Green fluorescence intensities. The mean fluorescence values for the vehicle control cells are indicated by vertical lines in each graph. (B) Quantitative evaluation of ROS in hDPCs. Data are presented as the mean ± SD (*n* = 4). ^∗∗∗^*P* \< 0.001, vs. control; ^\#^*P* \< 0.05, vs. H~2~O~2~ alone. (C) Representative dot plots of different groups based on JC-1 staining. Fluorescence intensity for JC-1 monomers (green) is plotted on the x-axis, with J-aggregates (red) plotted on the y-axis. (D) Mitochondrial membrane potential (Δψm), presented as red/green fluorescence, is shown. Data are presented as the mean ± SD (*n* = 6). ^∗∗∗^*P* \< 0.001, vs. control; ^*\#*^*P* \< 0.05, vs. H~2~O~2~ alone.Figure 4

Mitochondrial membrane potential (ΔΨm) was detected by JC-1, a sensitive fluorescent probe. In cells with high ΔΨm, JC-1 accumulates in the matrix of mitochondria, forming J-aggregates and showing red fluorescence, whereas in cells with low ΔΨm, JC-1 exists as a monomer, showing green fluorescence. The ΔΨm is indicated by the ratio of red/green fluorescence. As shown in [Fig. 4](#fig4){ref-type="fig"}C, D, H~2~O~2~ treatment caused ΔΨm loss in hDPCs (*P* \< 0.001) and melatonin significantly enhanced this in H~2~O~2~-exposed cells (*P* \< 0.05). However, with melatonin only, there was no significant difference in intracellular ROS levels and ΔΨm compared to those in controls.

Discussion {#sec4}
==========

Our study investigated the effect of melatonin on apoptosis of hDPCs, and H~2~O~2~ was used for this. Loss of cell viability is one characteristic of apoptotic cells and is a useful trait to monitor apoptosis.[@bib22] Based on cell viability assays, H~2~O~2~ at 500 μmol/L, which reduced viability of hDPCs by approximately 40%, was selected for other experiments. Our previous study showed that physiological concentrations of melatonin (10^−12^, 10^−10^, 10^−8^ mol/L) could inhibit proliferation of hDPCs.[@bib18] In the present study, the administration of physiological concentrations of melatonin for 24 h reduced hDPCs viability by 16--20%, and synergistically enhanced the H~2~O~2~-induced reduction in viability of hDPCs in a concentration-dependent manner.

DAPI is a blue fluorescent nuclear stain that can be used to visualize nuclear changes such as nuclear fragmented bodies and condensed or deformed nuclei during apoptosis or necrosis.[@bib22] Moreover, in apoptotic cells, membrane phosphatidyl serine (PS) from the inner leaflet of the plasma membrane is translocated to the outer component. Annexin V-FITC can specifically interact with PS, serving as a sensitive probe of cells undergoing apoptosis.[@bib23] In this study, we found that melatonin enhances H~2~O~2~-induced morphological changes in nuclei of hDPCs based on DAPI staining and elevated the proportion of Annexin V-positive cells in the presence of H~2~O~2~. These results were consistent with those of cell viability assays. Thus, we suggest that melatonin can enhance H~2~O~2~-induced apoptosis in hDPCs.

There are three main mechanisms that regulate apoptosis, namely the death receptor pathway, mitochondrial pathway, and endoplasmic reticulum pathway.[@bib24] Excessive H~2~O~2~ causes apoptosis via the mitochondrial death pathway, which commences with a transient increase in mitochondrial membrane hyperpolarization, causing a collapse in the ΔΨm, mitochondrial translocation of the pro-apoptotic proteins Bax and Bad, and release of cytochrome c from mitochondria to the cytoplasm.[@bib24]^,^[@bib25] Melatonin is a lipophilic molecule that can penetrate cellular and mitochondrial membranes, and was found to accumulate in mitochondria, indicating that this organelle might be a major target for melatonin. Further, it might interact with mitochondrial transition pores to elevate ROS production,[@bib26] and was found to induce mitochondrial permeability transition pores in human myeloid HL-60 cells.[@bib27] In our study, melatonin upregulated H~2~O~2~-induced intracellular ROS production and enhanced associated ΔΨm loss in hDPCs. We thus hypothesized that melatonin might influence H~2~O~2~-induced apoptosis of hDPCs through the mitochondrial pathway. Further studies will focus on the expression of mitochondrial pathway proteins such as Bcl-2, Bax, and cytochrome c.

The effect of melatonin on apoptosis is different in various cell types. For most tumor cells, it enhances apoptosis. Paradoxically, its effect is opposite in most normal cells. The neuroprotective effects of melatonin have been mostly studied, as it can reduce apoptosis in various neural cells.[@bib14] In addition, such effects were also observed in epithelial cells (e.g. retinal pigment epithelium cells,[@bib28] lens epithelial cells,[@bib29] cardiac microvascular endothelial cells)[@bib30] and stem cells (e.g. bone marrow stem cells,[@bib20] adipose-derived stem cells,[@bib21] haemopoietic cells).[@bib31] Interestingly, it was reported that melatonin enhances H~2~O~2~-induced apoptosis in human promyelocytic leukemia HL-60 cells, but increases the viability of healthy leucocytes exposed to H~2~O~2~.[@bib32] This dual effect might be explained by the different activity of respiratory complexes of diverse cell types.[@bib12] In a recent study, by measuring relevant mitochondrial respiration parameters in mesenchymal stem cells (MSCs) from different human tissues, MSCs from dental pulp were found to have higher mitochondrial respiratory abilities than MSCs from bone marrow and adipose.[@bib33] Thus, we speculated that mitochondrial respiratory abilities of hDPCs might be more similar to those of tumor cells, which could explain the enhanced H~2~O~2~-induced apoptosis of hDPCs with melatonin in our study.

Additionally, the effect of melatonin on apoptosis might be treatment-specific, as different concentrations could have disparate effects. At micro/millimolar levels (pharmacological concentrations, used in most studies), which are relatively higher than the physiological concentrations applied in this study, melatonin could directly scavenge hydroxyl and peroxyl radicals. However, in the picomolar range, melatonin has higher affinity for membrane receptors, the stimulation of which could decrease intracellular cAMP levels, thus activating different signal transduction pathways. In the nanomolar range, melatonin can activate the nuclear receptors RZR/RORα and RZRβ to regulate gene transcription.[@bib34] It was found that addition of the RZR/RORα ligand CGP52608 could increase cell death in an ovarian carcinoma cell line.[@bib35] Consequently, under physiological conditions, the effect of melatonin on apoptosis might be different.

H~2~O~2~ is commonly used in dental treatments such as tooth bleaching and root canal irrigating. It can penetrate enamel and dentine and reach the dental pulp chamber where hDPCs exist; moreover, the concentration of H~2~O~2~ that reaches the pulp chamber is higher in restorative teeth.[@bib36] Melatonin levels in the human body change with age and are low in infants, increasing significantly to peak at 1--3 years of age, and subsequently declining during puberty and in old age.[@bib37]^,^[@bib38] As we found that physiological concentrations of melatonin enhance H~2~O~2~-induced toxicity of hDPCs in a concentration-dependent manner, the overuse of H~2~O~2~ in dental procedures might be more harmful to the dental pulp in children and adolescents with higher melatonin levels than in adults. Consequently, H~2~O~2~ should be used with caution in pediatric dental patients.

In conclusion, our study showed that melatonin at physiological concentrations enhances the H~2~O~2~-induced loss of viability in hDPCs and promotes H~2~O~2~-induced apoptosis, with elevated intracellular ROS levels, and ΔΨm loss. Further studies are needed to examine whether melatonin enhances H~2~O~2~-induced apoptosis of hDPCs through the mitochondrial pathway.
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